Filing Summary
Business Context and Reporting Period
Catheter Precision, Inc. filed a Form 8-K reporting actions approved by its Board of Directors on September 24, 2026. The company plans to change its name to Flyte Aviation, Inc. and complete a 1-for-10 reverse stock split of its common stock.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other financial performance metrics.
Material Changes
- The name change and reverse stock split are expected to become effective at 12:01 a.m. Eastern Time on October 5, 2026, subject to filing the certificate of amendment with the Delaware Secretary of State.
- At the effective time, every 10 issued and outstanding or treasury shares will automatically combine into one share.
- No fractional shares will be issued; holders otherwise entitled to fractional shares will receive their pro rata share of the net proceeds from the sale of aggregated fractional shares.
- The common stock’s par value and authorized share count will not change.
- Outstanding equity awards, warrants, and convertible securities will be adjusted proportionately under their governing terms.
- The stock is expected to trade on a split-adjusted basis on NYSE American under the name Flyte Aviation, Inc. and ticker symbol VJET, beginning October 5, 2026. The post-split CUSIP is expected to be 74933X 807.
Guidance, Outlook, Risks, and Unusual Items
The filing provides no operating or financial guidance. The reverse stock split was approved by stockholders on April 15, 2026, while the Board selected the specific 1-for-10 ratio. The name change did not require stockholder approval under Delaware law.
Investor Verification Items
- Verify that the certificate of amendment is filed and that both actions become effective on October 5, 2026.
- Confirm the NYSE American listing name, ticker symbol VJET, and split-adjusted trading commencement.
- Review broker and transfer-agent treatment of fractional shares and account adjustments.
- Confirm the revised terms or share counts for outstanding equity awards, warrants, and convertible securities.
- Assess the company’s financial condition separately, as this 8-K does not report financial results or liquidity information.